Entrepreneur and Dallas Mavericks owner Mark Cuban voiced his support for the TrumpRx program and its Cost Plus Drugs model, describing the initiative as a major step toward price transparency and affordability in the U.S. pharmaceutical industry, as reported by The Gateway Hispanic.

Cuban called the program “amazing” and said it has the potential to deliver meaningful savings for seniors and patients nationwide.

Cuban, who founded CostPlusDrugs.com to simplify access to affordable medications, praised the TrumpRx program for its use of transparency as a tool to rebuild trust between patients and the healthcare system.

Trump's Sovereign Wealth Fund: What Could It Mean For Your Money?

The initiative allows consumers to see exactly how drug prices are calculated and how much profit is being made on each sale.

Through the TrumpRx API and the CostPlusDrugs.com platform, patients can view daily updates on drug prices that include full cost breakdowns and a flat 15% profit margin.

The approach removes layers of middlemen, including Pharmacy Benefit Managers (PBMs), who have long been blamed for inflating prescription costs.

“Trust is what we truly sell in this industry, and that has allowed us to grow so quickly,” Cuban said. He noted that by connecting manufacturers directly to patients, the TrumpRx model and the Most Favored Nation (MFN) program are making brand-name drugs more affordable and accessible.

This Could Be the Most Important Video Gun Owners Watch All Year

Cuban acknowledged that while the program does not fix every issue in the healthcare system, it represents a significant improvement in price clarity and patient savings.

Seniors—who are most affected by prescription costs—stand to benefit the most from these changes.

The entrepreneur also highlighted that the TrumpRx program’s structure reflects the broader goals of President Donald Trump’s administration: providing practical, market-based solutions that put patients first and reduce the influence of corporate intermediaries.

The program’s emphasis on consumer choice and transparency aligns with conservative efforts to create more accountability in healthcare spending.

“The combination of transparency, savings, and direct access to medications gives patients more control and confidence,” Cuban said. He emphasized that rebuilding public trust in healthcare depends on honest pricing and eliminating unnecessary costs.

Support from prominent business leaders like Cuban has brought renewed attention to TrumpRx’s promise of efficiency and cost reduction.

The initiative’s advocates argue that it showcases a model of free-market healthcare reform that delivers real benefits to citizens without additional government expansion.

As Cuban continues to champion affordable drug pricing, the TrumpRx program remains a focal point in the broader debate over how to lower healthcare costs while empowering patients through information and competition.